MiMedx Group Inc (MDXG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.30 is considered Undervalued compared with the five-year average of 9.81. The fair price of MiMedx Group Inc (MDXG) is between 57.26 to 60.83 according to relative valuation method. Compared to the current price of 4.88 USD , MiMedx Group Inc By Undervalued By 91.48%.

Relative Value

Fair Zone

57.26-60.83

Current Price：4.88

91.48%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is MiMedx Group Inc (MDXG) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

MiMedx Group Inc (MDXG) has a current Price-to-Book (P/B) ratio of 4.02. Compared to its 3-year average P/B ratio of 52.18, the current P/B ratio is approximately -92.30% higher. Relative to its 5-year average P/B ratio of 225.42, the current P/B ratio is about -98.22% higher. MiMedx Group Inc (MDXG) has a Forward Free Cash Flow (FCF) yield of approximately 6.96%. Compared to its 3-year average FCF yield of 3.15%, the current FCF yield is approximately 121.26% lower. Relative to its 5-year average FCF yield of 0.72%, the current FCF yield is about 860.96% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MDXG competitors is 111.49, providing a benchmark for relative valuation. MiMedx Group Inc Corp (MDXG.O) exhibits a P/S ratio of 2.30, which is -97.94% above the industry average. Given its robust revenue growth of 27.11%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MDXG increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MDXG in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MDXG currently overvalued or undervalued?

What is MiMedx Group Inc (MDXG) fair value?

MDXG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of MiMedx Group Inc (MDXG) is between 57.26 to 60.83 according to relative valuation method.

How does MDXG's valuation metrics compare to the industry average?

The average P/S ratio for MDXG's competitors is 111.49, providing a benchmark for relative valuation. MiMedx Group Inc Corp (MDXG) exhibits a P/S ratio of 2.30, which is -97.94% above the industry average. Given its robust revenue growth of 27.11%, this premium appears sustainable.

What is the current P/B ratio for MiMedx Group Inc (MDXG) as of Mar 03 2026?

As of Mar 03 2026, MiMedx Group Inc (MDXG) has a P/B ratio of 4.02. This indicates that the market values MDXG at 4.02 times its book value.

What is the current FCF Yield for MiMedx Group Inc (MDXG) as of Mar 03 2026?

As of Mar 03 2026, MiMedx Group Inc (MDXG) has a FCF Yield of 6.96%. This means that for every dollar of MiMedx Group Inc's market capitalization, the company generates 6.96 cents in free cash flow.

What is the current Forward P/E ratio for MiMedx Group Inc (MDXG) as of Mar 03 2026?

As of Mar 03 2026, MiMedx Group Inc (MDXG) has a Forward P/E ratio of 20.68. This means the market is willing to pay $20.68 for every dollar of MiMedx Group Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for MiMedx Group Inc (MDXG) as of Mar 03 2026?

As of Mar 03 2026, MiMedx Group Inc (MDXG) has a Forward P/S ratio of 2.30. This means the market is valuing MDXG at $2.30 for every dollar of expected revenue over the next 12 months.

MDXG Valuation